Rabies postexposure prophylaxis in routine practice in view of the new centers for disease control and prevention and world health organization recommendations

Clinical Infectious Diseases

Volumn 55, Issue 2, 2012, Pages 201-205

  Uwanyiligira, Mediatrice ^a   Landry, Pierre ^a   Genton, Blaise ^a,b   De Valliere, Serge ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABHAYRAB; MERIEUX; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL PRACTICE; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RABIES; RETROSPECTIVE STUDY; SCHOOL CHILD; SWITZERLAND; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CHILD, PRESCHOOL; FEMALE; GUIDELINES AS TOPIC; HEALTH SERVICES RESEARCH; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; POST-EXPOSURE PROPHYLAXIS; RABIES; RABIES VACCINES; RETROSPECTIVE STUDIES; SWITZERLAND; UNITED STATES; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84864141564     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis384     Document Type: Article

References (13)

1. WHO. Rabies vaccines: WHO position paper-recommendations. Vaccine 2010; 28:7140-2.
2. Federal Office of Public Health, Switzerland. Rabies pre-and postexposure prophylaxis in humans, 2004. Available at http://www.bag. admin.ch/themen/ medizin/00682/00684/01366/index.html?lang=fr. Accessed 26 April 2012.
3. Rupprecht CE, Briggs D, Brown CM, et al. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine 2009; 27:7141-8.
4. Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for post-exposure prophylaxis to prevent human rabies : recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010; 59(RR-2):1-9.
5. Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull WHO 1973; 48:535-41.
6. Zanoni RG, Bugnon P, Deranleau E, Nguyen TMV, Bruegger D. Walking the dog and moving the cat: rabies serology in the context of international pet travel schemes. Schweiz Arch Tierheilkd 2010; 152:561-8.
7. Shaw MT, O'Brien B, Leggat PA. Rabies postexposure management of travelers presenting to travel health clinics in Auckland and Hamilton, New Zealand. J Travel Med 2009; 16:13-7.
8. Wijaya L, Ford L, Lalloo D. Rabies postexposure prophylaxis in a UK travel clinic: ten years' experience. J Trav Med 2011; 18:257-61.
9. Zhang X, Zhu Z, Wang C. Persistence of rabies antibody 5 years after postexposure prophylaxis with Vero cell antirabies vaccine and antibody response to a single booster dose. Clin Vaccine Immunol 2011; 18:1477-9.
10. Jones RL, Froeschle JE, Atmar RL, et al. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell vaccine : a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 2001; 19:4635-43. (Pubitemid 32800745)
11. Bahmanyar M, Fayaz A, Nour-Salehi S, Mohammadi M, Koprowski H. Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 1976; 236:2751-4. (Pubitemid 8010765)
12. Aoki FY, Rubin ME, Fast MV. Rabies neutralizing antibody in serum of children compared to adults following post-exposure prophylaxis. Biologicals 1992; 20:283-7. (Pubitemid 23146640)
13. Briggs DJ, Banzhoff A, Nicolay U, et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 2000; 78:693-8. (Pubitemid 30398852)